Residual solvents in pharmaceutical are trace level impurities of organic volatile compounds used or produced in the manufacturing of active substances, excipients or preparation of medicinal products .The international conference on Harmonization (ICH) Q3C, United State pharmacopoeia (USP) method 467, and the European Pharmacopoeia 2.4.24 have set guideline to identify and quantify these solvents in pharmaceutical products to address the risk on human health.

GC-HS technique is used in identification and quantification of residual solvents in pharmaceutical products as per national and international Pharmacopoeia. Finar has developed range of GC HS solvents free from volatile impurities which could interfere in GC HS analysis.

  • Each batch is subjected to GC-HS analysis to ensure the suitability for residual analysis in excipients or API.
  • Solvents Specifications are designed for analysis of residual solvents conforming to USP, BP and JP.
  • Solvents are highly pure and have no interference peak in elution range of analytes.
Our range of GC-HS are:
SAP Code Products Pack size
90620LC100 Dimethyl sulphoxide GC-HS 1 Ltr
90620LM500 Dimethyl Sulphoxide GC-HS 500 ml
90590LC100 N,N-Dimethyl acetamide GC-HS 1 Ltr
90600LC100 N,N-Dimethyl formamide GC-HS 1 Ltr
90600LM500 N,N-Dimethyl formamide GC-HS 500 ml
90970LC100 N-Methyl 2-Pyrrolidone GC-HS 1 Ltr
90970LM500 N-Methyl-2-pyrrolidone GC-HS 500 ml